Establishment Labs Holdings Inc. (ESTA)
| Previous close | 56.87 |
| Open | 56.10 |
| Bid | 58.01 x 1000 |
| Ask | 58.56 x 1400 |
| Day's range | 54.87 - 58.56 |
| 52-week range | 46.93 - 93.80 |
| Volume | |
| Avg. volume | 224,880 |
| Market cap | 1.415B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Establishment Labs Reports Record First Quarter 2022 Financial Results
SANTA BARBARA, Calif., May 09, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.
- Business Wire
Establishment Labs to Announce First Quarter 2022 Financial Results on May 9
SANTA BARBARA, Calif., April 28, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.
- Business Wire
Establishment Labs Enters Into $225 Million Credit Facility With Oaktree
SANTA BARBARA, Calif., April 26, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management, L.P. ("Oaktree").
